Chunxiao Zhang is a Neurology physician. OpenAlex indexes 121 publications with 1,430 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2900 Lamb Cir Ste 230
Christiansburg, VA 240736341
Telephone
540-224-5170Provider last certified this registry record 22 Sept 2025.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SK Life Science, Inc.Program year20251 payment
- ACADIA Pharmaceuticals IncProgram year20251 payment
- Neurelis, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
70.4%Neuromuscular Blocker69.4%Onabotulinumtoxina100%Part B, office-administered≥12 patientsCentral alpha-2 Adrenergic Agonist0.6%Tizanidine Hcl100%Part D≥16 patients+ 1 more class in this area
Nervous system
27.8%Other antiepileptics7.9%Levetiracetam36%Topiramate33%Lacosamide16%Xcopri10%Topiramate Er2%Briviact1%Levetiracetam Er1%Part D<11 patientsMood Stabilizer3.6%Lamotrigine54%Carbamazepine14%Lamotrigine Er13%Valproic Acid11%Carbamazepine Er5%Lamictal3%Part D<11 patients+ 20 more classes in this area
Cardiovascular
1.1%Beta blocker1%Propranolol Hcl64%Propranolol Hcl Er25%Nadolol11%Part D<11 patientsCalcium channel blocker0.1%Verapamil Sr100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- RETRACTED: Mitigating effects of hydroxysafflor yellow a on atherosclerotic inflammatory responses based on flavonoid macromolecule compound: Inhibition of Piezo1-YAP/JNK protein pathway
International Journal of Biological Macromolecules
2025 - Ball-milling of titanium dioxide and zinc oxide for enhanced UV protection
Frontiers in Materials
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”